XML 71 R57.htm IDEA: XBRL DOCUMENT v3.8.0.1
3. Fair Value Measurements Contingent Consideration (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended 13 Months Ended 36 Months Ended 51 Months Ended 52 Months Ended
Sep. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2020
Dec. 31, 2016
Feb. 01, 2017
Jan. 06, 2016
Apr. 10, 2014
Sep. 30, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value     $ 28.5       $ 28.5        
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability   $ (18.1) (0.4) $ (5.6)              
Fair Value, Measurements, Recurring [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business Combination, Contingent Consideration, Liability [1]   16.7 38.5   $ 16.7   38.5        
CellSorter [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business Combination, Contingent Consideration, Liability   3.1     3.1           $ 44.6
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements   (3.1)           $ (32.0)      
Net (decrease) increase in estimated fair value of contingent consideration included in selling, general and administrative expense             (12.6)        
Analytical Flow Cytometer Platform [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value   16.7     16.7            
Business Combination, Contingent Consideration, Liability   16.7     16.7       $ 23.3    
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements $ (0.6) (0.6)                  
Net (decrease) increase in estimated fair value of contingent consideration included in selling, general and administrative expense   $ (8.1)     $ 6.0            
GnuBIO [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business Combination, Contingent Consideration, Liability     $ 10.0       $ 10.0     $ 10.7  
Discount rate [Member] | Analytical Flow Cytometer Platform [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Fair Value Inputs, Discount Rate   10.80%                  
Sales milestone percentage of annual invoices [Member] | Analytical Flow Cytometer Platform [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business Acquisition, Contingent Consideration, Potential Percentage Payout   39.00%     39.00%            
Sales milestone percentage of annual invoices low [Member] | Analytical Flow Cytometer Platform [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business Acquisition, Contingent Consideration, Potential Percentage Payout   20.00%     20.00%            
Sales milestone minimum amount [Member] | Analytical Flow Cytometer Platform [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low   $ 0.0     $ 0.0            
Cost of debt [Member] | Analytical Flow Cytometer Platform [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Fair Value Inputs, Discount Rate   4.20%                  
Scenario, Forecast [Member] | Analytical Flow Cytometer Platform [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High           $ 78.0          
[1] Contingent consideration liabilities are included in the following accounts in the Consolidated Balance Sheets (in millions):
 
December 31, 2017
 
December 31, 2016
 
 
 
 
Other current liabilities
$
2.7

 
$
14.5

Other long-term liabilities
14.0

 
24.0

   Total
$
16.7

 
$
38.5